Back to Trades
Redmile Group, LLC
Director10% OwnerCIK 0001425738
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 4
- Active
- 2025–2026
Redmile Group, LLC, Director, 10% Owner, has filed 8 reports across 4 companies, totaling $24.3M in disclosed volume. Sales ($19.6M) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Jun 15 | FATE FATE THERAPEUTICS INC | Redmile Group, LLC | Director, 10% Owner | Other | $0 |
| Apr 23 | FATE FATE THERAPEUTICS INC | Redmile Group, LLC | Director, 10% Owner | Other | $0 |
| Apr 22 | FATE FATE THERAPEUTICS INC | Redmile Group, LLC | Director, 10% Owner | Other | $0 |
| Apr 2 | ADCT ADC Therapeutics SA | Redmile Group, LLC | 10% Owner | Sell | $19.6M |
| Oct 28 | ADCT ADC Therapeutics SA | Redmile Group, LLC | 10% Owner | Other | $0 |
| Aug 26 | STTK Shattuck Labs, Inc. | Redmile Group, LLC | Director, 10% Owner | Other | $0 |
| Aug 15 | IGMS IGM Biosciences, Inc. | Redmile Group, LLC | Director, 10% Owner | Other | $0 |
| Jul 16 | STTK Shattuck Labs, Inc. | Redmile Group, LLC | Director, 10% Owner | Other | $0 |
8 filings